Sort
64,565 grants matching “drug discovery”
Small Molecule Screening and Medicinal Chemistry Core
$1,211,395Stephen Lory · Harvard Medical School · U54 · FY2009 · AI
Contraception by Blockade of Periovulatory Events in Primates
$1,211,279Richard L Stouffer · Oregon Health & Science University · U54 · FY2008 · HD
Thiolactomycin Acid Derivatives as Novel Antibacterials
$1,211,279Glaxosmithkline · UC1 · FY2000 · AI
Validation of targets for therapeutic intervention in NASH
$1,211,258Brian Robert Wamhoff · Hemoshear Therapeutics, Llc · R44 · FY2017 · DK
The Role of B cells in the Origin and Progression of Multiple Sclerosis
$1,211,237Stephen L Hauser · University Of California, San Francisco · R35 · FY2025 · NS
Biochemical and Structural Studies of Viral Proteases
$1,210,993John Louis · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Rhythmicity and Synchrony in the Basal Ganglia
$1,210,543Dalton James Surmeier · Northwestern University At Chicago · P50 · FY2012 · NS
Validation of a human in vitro system of hepatic steatohepatitis
$1,210,475Brian Robert Wamhoff · Hemoshear Therapeutics, Llc · R44 · FY2016 · DK
Integrative Omics as a Discovery Tool for Pulmonary Hypertension
$1,210,211Marlene Rabinovitch · Stanford University · R01 · FY2017 · HL
Integrated Technologies for Polymeric Biomaterials, RESBIO
$1,210,046Joachim B. Kohn · Rutgers, The State Univ Of N.J. · P41 · FY2016 · EB
Functional genomics and DEC-Tec to identify germ cell-specific contraceptives
$1,209,970Martin M Matzuk · Baylor College Of Medicine · P01 · FY2021 · HD
Amish Connectome Project on Mental Illness
$1,209,910L. Elliot Hong · University Of Maryland Baltimore · U01 · FY2018 · MH
Integrated Technologies for Polymeric Biomaterials, RESBIO
$1,209,869Joachim B. Kohn · Rutgers, The State Univ Of N.J. · P41 · FY2017 · EB
Discovery of solubilizing side chains for in vivo release of diverse drug classes using the Click Activated Protodrugs (CAP) platform
$1,209,827Nathan Yee · Tambo, Inc. · R44 · FY2025 · TR
Development of ureadepsipetides for drug-resistant infections
$1,209,617Michael Lafleur · Arietis · R01 · FY2021 · AI
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
$1,209,563Xiaodong Cheng · University Of Texas Hlth Sci Ctr Houston · R01 · FY2017 · AI
CLINICAL TRIAL PROTOCOLS FOR ACUTE ISCHEMIC STROKE
$1,208,664Steven Jay Warach · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
NOVEL INSIGHTS INTO CEREBRAL ISCHEMIC PATHOPHYSIOLOGY IN HUMANS
$1,208,664Steven Jay Warach · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
Dartmouth Lung Biology Center for Molecular, Cellular and Translational Research
$1,208,390Bruce A. Stanton · Dartmouth College · P30 · FY2013 · GM
Driving Medical Projects (4 of 4)
$1,208,251Edward Mark Scolnick · Broad Institute, Inc. · RL1 · FY2010 · GM
DartCF: The Dartmouth Cystic Fibrosis Research Center
$1,208,158Dean R Madden · Dartmouth College · P30 · FY2021 · DK
DartCF: The Dartmouth Cystic Fibrosis Research Center
$1,208,158Dean R Madden · Dartmouth College · P30 · FY2023 · DK
DartCF: The Dartmouth Cystic Fibrosis Research Center
$1,208,158Dean R Madden · Dartmouth College · P30 · FY2024 · DK
Novel Molecular Therapies of Prostate Cancer
$1,208,002Dario C. Altieri · Wistar Institute · P01 · FY2020 · CA
SBIR Phase II: High throughput and antigen specific T-cell receptor discovery for solid tumor treatments
$1,207,999Binbin Chen · Vcreate, Inc. · · FY2024 · TIP